论文部分内容阅读
本文介绍新型呼吸兴奋剂阿米脱林的药理学研究资料和临床应用情况。本药可用于各种慢性阻塞性肺疾患,伴有急、慢性呼吸衰竭者,亦可在人工呼吸治疗的同时,作为辅助治疗,或用于长期家庭氧疗者,以减少氧气和茶碱等的用量。本药的作用机理可能与刺激外周化学感受器和改善肺内气体和血流分布不均有关。并与用药途径及用药剂量有关。尚待继续研究。
This article describes the pharmacological data and clinical application of the new respiratory stimulant amlibarin. The drug can be used for a variety of chronic obstructive pulmonary disease, with acute and chronic respiratory failure, but also in the artificial respiratory therapy, as adjuvant therapy, or long-term home oxygen therapy to reduce oxygen and theophylline, etc. The amount of The mechanism of action of this drug may be related to stimulating peripheral chemoreceptors and improving uneven distribution of gas and blood flow in the lung. And with the way and dose of medication. Still to be studied.